2005

• ANDX Feline Sarcoma Predisposition Test entered beta-test phase
• ANDX President invited to present at the United States Congressional Biotechnology Caucus meetings in Washington, DC.
• We've moo..ved! ANDX laboratories and offices relocated into newly constructed laboratory and office space at 1000 Westgate Drive, St. Paul, MN 55114.
• ANDX scientists invited to present at hearings on bio-defense and homeland security to the Minnesota House of Representatives.
• ANDX scientists invited to demonstrate food bio-defense research to Secretary for Homeland Security, Michael Chertoff.
• ANDX showcased new diagnostic technologies at the annual convention of the American Veterinary Medical Association, Minneapolis.
  

2004

• ANDX is accredited by the USDA for direct molecular detection of Mycobacterium avium sub-species para-tuberculosis (MAP, causative agent for Johne's disease) in cattle.
• ANDX scientists invited to demonstrate food bio-defense research to Secretary for Homeland Security, Tom Ridge & Secretary of Agriculture, Ann Venemun.
• ANDX awarded funding from the Department of Homeland Security' National Center for Food Protection and Defense for research project on rapid diagnostic technologies.
• ANDX launches it's Johne's Disease molecular diagnostic program.
• ANDX joins the Minnesota State BioScience Program.
  

• Complete genome sequence of M. paratuberculosis published in the Proceedings of the National Academy of Sciences - 2005
• Largest project competitively funded by the USDA on Johne's Disease research - 2004
  

2003

• ANDX accredited by the USDA for direct molecular detection of MAP in cattle.
• ANDX laboratory set up at the "Biodale" biotech facilities of the University of Minnesota.
• ANDX licenses worldwide exclusive rights to Mycobacterium avium subspecies paratuberculosis (MAP) technology invented at the University of Minnesota and the United States Department of Agriculture.
• ANDX licenses worldwide exclusive rights to technologies associated with testing for genetic predispositions to cancer and other pathologies from the University of Minnesota
  
  

2002

• ANDX formed by co-founders:
  Vivek Kapur, BVSc, MS, PhD &
  Sagarika Kanjilal, PhD, PhD